Montreal scientists play key role in long-term international study Rate of change in the thickness of the brain’s cortex is an important factor associated with a person’s change in IQ, according to a collaborative study by scientists in five countries including researchers at the Montreal Neurological Institute and Hospital – The Neuro, at McGill University and the McGill University Health Centre.
Dr. Brenda Milner, an active researcher at the age of 95 at the Montreal Neurological Institute and Hospital, McGill University, has been awarded the 2014 Dan David Prize for her fundamental contributions to the science of memory and the brain. Dr. Milner is widely recognized as one of the founders of cognitive neuroscience–the field that brings together brain and behavior. Dr. Milner, who is the Dorothy J. Killam Professor of Psychology, shares the Prize for the category Present: “Combatting Memory Loss”, with Peter St. George-Hyslop (University of Cambridge) and John A.
Scientists from the Montreal Neurological Institute and Hospital in Canada have discovered that two genes linked to hereditary Parkinson’s disease are involved in the early-stage quality control of mitochondria. The protective mechanism, which is reported in The EMBO Journal, removes damaged proteins that arise from oxidative stress from mitochondria.
William Feindel, O.C., G.O.Q., MDCM, D. Phil 1918 – 2014 The Montreal Neurological Institute and Hospital, McGill University and the McGill University Health Centre regret to announce the death of William Feindel, O.C., G.O.Q., MDCM, D. Phil., one of Canada's most distinguished neurosurgeons and The Neuro’s third director. Dr. Feindel passed away quietly at The Neuro on Sunday night following a brief illness. Our deepest sympathies go out to Dr. Feindel’s family.
The BigBrain atlas developed by Dr. Alan Evans and colleagues at The Neuro’s Brain Imaging Centre has been chosen as one of the top 10 discoveries of the year in Quebec Science. BigBrain: a revolutionary new 3D digital brain atlas
Mechanism meant to maintain efficiency of brain network involved in neurodegenerative disease
As part of The Neuro’s Thinking Ahead Campaign, a $240,000 donation from Desjardins Group, the largest financial cooperative group in Canada, to The Montreal Neurological Institute and Hospital – The Neuro, McGill University has enabled the creation of the Desjardins Outstanding Student Award. Twelve awards of 20 000 $ each will support top-rated graduate students and postdoctoral fellows who are advancing research to better understand the nervous system and neurological disorders and aid in developing new therapies.
Scientists at The Neuro find important time factor in second-language acquisition The age at which children learn a second language can have a significant bearing on the structure of their adult brain, according to a new joint study by the Montreal Neurological Institute and Hospital - The Neuro at McGill University and Oxford University. The majority of people in the world learn to speak more than one language during their lifetime. Many do so with great proficiency particularly if the languages are learned simultaneously or from early in development.
Imagine being able to zoom into the brain to see various cells the way we zoom into Google maps of the world and can see houses on a street. And keep in mind that the brain is considered the most complex structure in the universe with 86 billion neurons. Zooming in is now possible thanks to a new brain atlas with unprecedented resolution. BigBrain is the first 3D microstructural model of the entire human brain, and is free and publicly available to researchers world-wide.
A new study shows that memory pathology in older mice with Alzheimer’s disease can be reversed with treatment. The study by researchers from the Montreal Neurological Institute and Hospital - The Neuro, at McGill University and at Université de Montréal found that blocking the activity of a specific receptor in the brain of mice with advanced Alzheimer’s disease (AD) recovers memory and cerebrovascular function.
Arthritis is a debilitating disorder affecting one in 10 Canadians, with pain caused by inflammation and damage to joints.
What is ALS?Amyotrophic Lateral Sclerosis (ALS) also known as Lou Gehrig’s disease, is a neurodegenerative disease in which progressive muscle weakness leads to paralysis. ALS is a result of the death of motor neurons (nerve cells) in the brain and spinal cord that control voluntary muscle movement. Most people survive less than five years following diagnosis, but a small percentage of patients live for ten years or even longer. So far, there is no cure.